2-氨基-4,5,6,7-四氢-苯并[b]噻吩-3-羧酸 (4-甲氧基-苯基)酰胺 | 83822-33-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-4,5,6,7-四氢-苯并[b]噻吩-3-羧酸 (4-甲氧基-苯基)酰胺
• 中文别名: 2-氨基-N-(4-甲氧苯基)-4,5,6,7-四氢苯并噻吩-3-甲酰胺
• 英文名称: 2-amino-4,5,6,7-tetrahydro-N-(4-methoxyphenyl)benzo[b]thiophene-3-carboxamide
• 英文别名: 2-amino-N-(4-methoxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
• CAS: 83822-33-7
• 化学式: C₁₆H₁₈N₂O₂S
• mdl: MFCD01176766
• 分子量: 302.397
• InChiKey: ZVCHKLYMJWMDHO-UHFFFAOYSA-N

物化性质

• 沸点：
  466.6±45.0 °C(Predicted)
• 密度：
  1.309±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.312
• 拓扑面积：
  92.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  2-氨基-4,5,6,7-四氢-苯并[b]噻吩-3-羧酸 (4-甲氧基-苯基)酰胺 、 原甲酸三乙酯 在 三氯氧磷 作用下， 以 甲苯 为溶剂， 反应 1.0h， 以58%的产率得到3-(4-Methoxy-phenyl)-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d]pyrimidin-4-one
  参考文献：
  名称：

  Schellhase; Bohm; Pech, Pharmazie, 1984, vol. 39, # 1, p. 19 - 21

  摘要：

  DOI：
• 作为产物：
  描述：

  2-Cyano-2-cyclohexylidene-N-(4-methoxy-phenyl)-acetamide 在 二乙胺 作用下， 以 乙醇 为溶剂， 反应 3.0h， 以65%的产率得到2-氨基-4,5,6,7-四氢-苯并[b]噻吩-3-羧酸 (4-甲氧基-苯基)酰胺
  参考文献：
  名称：

  Schellhase; Bohm; Pech, Pharmazie, 1984, vol. 39, # 1, p. 19 - 21

  摘要：

  DOI：

文献信息

• Barium aluminate nano-powders efficient catalyst for the synthesis of novel benzo[b]thiophene, thieno[2,3-c]thiopyran and thieno[2,3-c]pyridine derivatives
  作者：Hossein Yarahmadi、Majid Ghashang、Saeid Jabbar Zare、Alireza Khodaivandi

  DOI：10.1080/10426507.2017.1295961

  日期：2017.8.3

  aluminate (BaAl2O4) can be synthesized by a facile solution reaction at room temperature using barium and aluminum salts and 2-aminoethanol as a precipitating agent. The as-prepared sample showed a good reactivity in the synthesis of benzo[b]thiophene, thieno[2,3-c]thiopyran and thieno[2,3-c]pyridine derivatives. Comparatively the method is efficient and eco-friendly, and finally, a range of compounds with

  图形摘要摘要 铝酸钡 (BaAl2O4) 的均匀纳米粉末可以在室温下使用钡盐和铝盐以及 2-氨基乙醇作为沉淀剂通过简单的溶液反应合成。所制备的样品在苯并[b]噻吩、噻吩并[2,3-c]噻喃和噻吩并[2,3-c]吡啶衍生物的合成中显示出良好的反应性。相比之下，该方法高效且环保，最终可以以优异的收率获得一系列具有可变功能的化合物。
• Heterobicyclic Compounds as Pharmaceutically Active Agents
  申请人：Koul Anil

  公开号：US20070275962A1

  公开（公告）日：2007-11-29

  Described are heterobicyclic compounds such as 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]thiopyran 3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid amides, or benzo[b]thiophene-3-carboxylic acid amides and pharmaceutically acceptable salts thereof, the use of these derivatives for the prophylaxis and/or treatment of various diseases such as infectious diseases, including mycobacteriainduced infections and opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as compositions containing at least one heterobicyclic compound and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the heterobicyclic compound are disclosed.

  本文介绍了异杂双环化合物，例如4,5,6,7-四氢苯并[b]噻吩-3-羧酸酰胺，4,7-二氢-5H-噻吩[2,3-c]硫杂吡喃-3-羧酸酰胺，4,7-二氢-5H-噻吩[2,3-c]吡喃-3-羧酸酰胺，或苯并[b]噻吩-3-羧酸酰胺及其药学上可接受的盐。这些衍生物的用途包括预防和/或治疗各种疾病，如传染性疾病，包括分支杆菌感染和机会性疾病，朊病，免疫性疾病，自身免疫性疾病，双相和临床障碍，心血管疾病，细胞增殖性疾病，糖尿病，炎症，移植排斥，勃起功能障碍，神经退行性疾病和中风，以及含有至少一种异杂双环化合物和/或药学上可接受的盐的组合物。此外，还公开了合成异杂双环化合物的反应程序。
• Tetrahydrobenzothiophene compound
  申请人：Astellas Pharma Inc.

  公开号：US08729068B2

  公开（公告）日：2014-05-20

  The purpose is to provide a compound which has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia. A tetrahydrobenzothiophene compound of the following formula (I) has NPT-IIb inhibitory action and can be used as an agent for treating and/or preventing hyperphosphatemia: wherein, R1 represents —O-lower alkyl, -lower alkylene-phenyl, or the like; R2 and R3 are the same as or different from each other and represent H, lower alkyl, cycloalkyl, aryl, heteroaryl or the like, or, R2 and R3 may be combined with a nitrogen atom to which they bind to form 5- to 7-membered saturated cyclic amino; R4's are the same as or different from each other and represent halogen, lower alkyl; and n represents 0 to 2.

  本发明的目的是提供一种具有肠道磷酸盐转运体（NPT-IIb）抑制作用的化合物，可用作治疗和/或预防高磷血症的药物活性成分。以下式（I）的四氢苯并噻吩化合物具有NPT-IIb抑制作用，可用作治疗和/或预防高磷血症的药物：其中，R1代表-O-较低烷基，-较低烷基-苯基或类似物；R2和R3相同或不同，代表H，较低烷基，环烷基，芳基，杂环芳基或类似物，或R2和R3可以与它们结合的氮原子形成5-至7-成员饱和环氨基；R4相同或不同，代表卤素，较低烷基；n代表0至2。
• Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
  申请人：——

  公开号：US20040171603A1

  公开（公告）日：2004-09-02

  Described herein is the discovery that certain mycobacterial serine/threonine protein kinases, particularly protein kinase G (PknG), are effective therapeutic targets for the treatment of mycobacterial infections. Furthermore, the present application refers to the use of mycobacterial serine/threonine protein kinases for developing methods for detection and determination of these kinases for recognizing and monitoring diseases and for controlling therapy of diseases. Additionally disclosed are novel 4,5,6,7-tetrahydrobenzo[b]thiophene compounds, benzo(g)quinoxaline compounds, and pharmaceutically acceptable salts thereof, and methods of using such compounds and salts thereof for the prophylaxis and/or treatment of virally and/or bacterially induced infections, particularly mycobacteria-induced infections, including opportunistic infections, as well as pharmaceutical compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene compound and/or benzo(g)quinoxaline compound and/or pharmaceutically acceptable salts thereof in a pharmaceutically acceptable carrier.

  本文描述的是发现某些分枝杆菌丝氨酸/苏氨酸蛋白激酶，特别是蛋白激酶 G (PknG)，是治疗分枝杆菌感染的有效治疗靶点。此外，本申请还涉及利用分枝杆菌丝氨酸/苏氨酸蛋白激酶开发检测和测定这些激酶的方法，用于识别和监测疾病以及控制疾病的治疗。此外，还公开了新型 4,5,6,7-四氢苯并[b]噻吩化合物、苯并（g）喹喔啉化合物及其药学上可接受的盐，以及使用此类化合物及其盐预防和/或治疗病毒和/或细菌引起的感染，特别是分枝杆菌引起的感染（包括机会性感染）的方法，以及含有至少一种 4,5,6,7-四氢苯并&lsqb；b]噻吩化合物和/或苯并(g)喹喔啉化合物和/或其药学上可接受的盐，并将其置于药学上可接受的载体中。
• ——
  作者：

  DOI：——

  日期：——